EVAX vs JBDI Comparison

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

JBDI Holdings Ltd, through its subsidiaries, is mainly engaged in the reconditioning and recycling of containers in Singapore. Its products include reconditioned and new steel drums, plastic drums, carboys, and IBCs with different capacities, and its customers span various industries such as the solvent, chemical, petroleum, and edible oil industries. Additionally, the Group offers ancillary services, such as reconditioning services, wastewater equipment services, and sales of recycled materials and services to complement its core business. The majority of its revenue is derived from the sale of reconditioned containers. Geographically, the Group derives all its revenue from Singapore.